Krempa David 4
4 · Eton Pharmaceuticals, Inc. · Filed Jun 16, 2025
Insider Transaction Report
Form 4
Krempa David
Chief Business Officer
Transactions
- Sale
Common Stock
2025-06-12$14.92/sh−16,977$253,297→ 629,669 total - Sale
Common Stock
2025-06-13$14.77/sh−6,800$100,436→ 622,869 total - Sale
Common Stock
2025-06-16$14.73/sh−10,223$150,585→ 612,646 total
Footnotes (4)
- [F1]The shares were sold in multiple trades at prices ranging from $14.77 to $14.98. The price reported above reflects the weighted average sales price.
- [F2]The shares were sold in multiple trades at prices ranging from $14.75 to $14.81. The price reported above reflects the weighted average sales price.
- [F3]The shares were sold in multiple trades at prices ranging from $14.50 to $14.79. The price reported above reflects the weighted average sales price.
- [F4]The Reporting Person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.